Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.295 USD | +4.85% | -12.19% | -17.91% |
Apr. 16 | Foghorn Therapeutics Names Kristian Humer CFO | MT |
Apr. 16 | Foghorn Therapeutics Inc. Appoints Kristian Humer as Chief Financial Officer | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- FHTX Stock
- Revisions Foghorn Therapeutics Inc.